Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study

Authors :: William V Tamborlane
Lori M Laffel
Naim Shehadeh
Elvira Isganaitis
Michelle Van Name
Jayantha Ratnayake
Cecilia Karlsson
Ensio Norjavaara
Source :: The Lancet Diabetes & Endocrinology. 10:341-350
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Subjects :: Endocrinology
Endocrinology, Diabetes and Metabolism
Internal Medicine

Full Text Access

Tools